Women who had chemotherapy less likely to be employed 4 years later
Nearly one-third of breast cancer survivors who were working when they began treatment were unemployed four years later. Women who received chemotherapy were most affected, according to a new study from the University of Michigan Comprehensive Cancer Center.
This is Reshma Jagsi, M.D., D.Phil
Credit: University of Michigan Health System
Researchers surveyed woman in Detroit and Los Angeles who had been diagnosed with early stage breast cancer. They narrowed their sample to the 746 women who reported working at the time they were diagnosed. Participants were surveyed about nine months after diagnosis, and then given a follow-up survey about four years later.
Overall, 30 percent of these working women said they were no longer working at the time of the four-year follow-up survey. Women who received chemotherapy were more likely to report that they were not working four years later.
Many of these women reported that they want to work: 55 percent of those not working said it was important for them to work and 39 percent said they were actively looking for work. Those who were not working were significantly more likely to report they were worse off financially. Results of the study appear in the journal Cancer.
"Many doctors believe that even though patients may miss work during treatment, they will 'bounce back' in the longer term. The results of this study suggest otherwise. Loss of employment is a possible long-term negative consequence of chemotherapy that may not have been fully appreciated to date," says lead study author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Medical School.
Many patients take time off of work during chemotherapy treatment to deal with the immediate side effects of the therapy. The researchers say it's possible this may lead to long-term employment problems. In addition, chemotherapy treatments can cause long-term side effects such as neuropathy or cognitive issues, which might also affect job prospects.
The findings point to the need to reduce the burden of breast cancer treatment, and reinforce current efforts to develop better strategies for identifying patients less likely to benefit from chemotherapy.
Breast cancer statistics: 235,030 Americans will be diagnosed with breast cancer this year and 40,430 will die from the disease, according to the American Cancer Society
Additional authors: Sarah T. Hawley, Ph.D.; Paul Abrahamse, M.A.; Yun Li, Ph.D.; Nancy K. Janz, Ph.D.; Jennifer J. Griggs, M.D., M.P.H.; Steven Katz, M.D., M.P.H., all from the University of Michigan; Cathy Bradley, Ph.D., from Virginia Commonwealth University; John J. Graff, Ph.D., Cancer Institute of New Jersey; Ann Hamilton, Ph.D., University of Southern California
Funding: National Cancer Institute grants R01 CA109696, R01 CA088370, K05 CA 111340; American Cancer Society
Reference: Cancer, published online April 28, 2014
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, http://www.mcancer.org
Clinical trials at U-M, http://www.mcancer.org/clinicaltrials
mCancerTalk blog, http://uofmhealthblogs.org/cancer
Nicole Fawcett | Eurek Alert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine